Eddy Luh, MD
Vascular Surgery · Las Vegas, NVNPI 1043364532
Payments from drug & device makers
Across 258 payments — averaging $133.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$21K
- Silk Road Medical, Inc.$3K
- Boston Scientific$2K
- Lemaitre Vascular, Inc.$1K
- W. L. Gore & Associates, Inc.$811
- Surmodics, Inc.$786
- plus $5K from 33 others
What the payments were for
- Consulting fees$15,40045%
- Travel & lodging$1,4674%
- Food & beverage$17,51351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 42 | $21,484 |
| Silk Road Medical, Inc. | 30 | $2,775 |
| Boston Scientific | 47 | $2,350 |
| Lemaitre Vascular, Inc. | 17 | $1,228 |
| W. L. Gore & Associates, Inc. | 10 | $811 |
| Surmodics, Inc. | 5 | $786 |
| Shockwave Medical, Inc | 14 | $740 |
| Penumbra, Inc. | 4 | $443 |
| Inspiremd Ltd | 4 | $431 |
| Koya Medical, Inc. | 2 | $412 |
| Cardiovascular Systems Inc. | 17 | $264 |
| Reflow Medical Inc | 1 | $251 |
| Medtronic(2 entities) | 8 | $239 |
| Johnson & Johnson(2 entities) | 10 | $208 |
| Veryan Medical Incorporated | 2 | $201 |
| Bolton Medical Inc | 1 | $173 |
| Abbott | 2 | $143 |
| Philips North America LLC | 1 | $143 |
| Cvrx, Inc. | 1 | $143 |
| Bard Peripheral Vascular, Inc. | 5 | $132 |
| Aroa Biosurgery Incorporated | 4 | $127 |
| KCI USA, Inc. | 1 | $101 |
| Organogenesis Inc. | 2 | $91 |
| Angiodynamics, Inc. | 3 | $88 |
| Asahi Intecc USA, Inc. | 1 | $87 |
| Kerecis Limited | 5 | $72 |
| Tactile Systems Technology Inc | 4 | $69 |
| Stryker | 1 | $69 |
| CSL Behring | 1 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Coloplast | 1 | $43 |
| Cook Medical LLC | 2 | $36 |
| Nevro Corp. | 1 | $30 |
| Covidien LP | 2 | $25 |
| Olympus America Inc. | 1 | $22 |
| Sanara Medtech Inc. | 1 | $20 |
| Inari Medical, Inc. | 1 | $19 |
| Acell, Inc. | 1 | $18 |
| Hologic Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Alto Abdominal Stent Graft System$15,350
- AFX2 Bifurcated Endograft System$4,500
- ENROUTE Transcarotid Neuroprotection System$2,560
- ENDOCROSS Device$2,449
- Torus Stent Graft System$2,449
- ENHANCE Transcarotid Peripheral Access Kit$1,781
- ENROUTE Transcarotid Stent$1,366
- Dayspring$1,166
- ENROUTE .014 Guidewire$944
- ENROUTE Transcarotid Stent System$837
- ENROUTE 0.014 Guidewire$837
- Sublime 014 Rx PTA Balloon Dilatation Catheter$786
- Sublime Microcatheter, 018, 200cm, Straight$786
- Pounce Thrombectomy System$786
- Pounce Thrombectomy$786
- Pounce Venous Thrombectomy System$786
- JETSTREAM$637
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$529
- TRIVEX$500
- AFX$481
How this compares
$34,380 in reported general payments places this provider in the 85th percentile of 28 vascular surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 16 | $18,519 |
| ClopidogrelClopidogrel Bisulfate | 131 | $1,411 |
| Cilostazol | 15 | $562 |
| Prednisone | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $208 | $18,51916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 28 vascular surgery providers in Nevada.
Other vascular surgery in Las Vegas
- George PliagasLas Vegas$211K
- Sai KottapalliLas Vegas$53K
- Earl CottrellLas Vegas$30K
- Bruce HirschfeldLas Vegas$28K
- Alvancin LouisLas Vegas$17K
- Amir GhaffarianLas Vegas$14K
- Rohan KulkarniLas Vegas$9K
- Alexander GidayaLas Vegas$9K
- Alex LallLas Vegas$8K
- Peter LeeLas Vegas$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.